Introduction
Total hip arthroplasty (THA) is now the most widely used surgical procedure in the treatment of avascular necrosis (AVN) of the femoral head [1] . At the Hip Society symposium held in 2013, a significant increase in the use of THA to treat AVN and a sharp decline in conservative procedures were reported [2] .
Nevertheless, the outcomes of THA for femoral head AVN remain controversial, particularly when cementless implants are used [3] [4] [5] [6] [7] [8] . The few studies comparing THA for AVN and osteoarthritis showed poorer outcomes in the AVN groups. Recently, however, improvements in outcomes of cementless THA for AVN have been reported [9, 10] . It has been suggested that the poorer outcomes of THA for AVN may be related to the cause of AVN or to a history of hip surgery before THA [11] [12] [13] [14] .
We therefore conducted a prospective case-control study to determine if differences existed between THA for AVN and osteoarthritis in terms of (a) survival, (b) complication rates, (c) functional outcomes and radiographic outcomes, (d) and to determine whether specific risk factors for THA failure exist in femoral head AVN. Our working hypothesis was that survival of anatomical cementless metal-on-metal 28-mm THA was similar in AVN and osteoarthritis.
Material and methods

Patients
From 1997 to 2007, a single-center prospective study included consecutive patients undergoing THA for AVN or osteoarthritis. Inclusion criteria were age younger than 65 years at THA and implantation of the Omnicase TM anatomical cementless stem (Zimmer, Warsaw, IN, USA) and of a Schuster TM cementless metal-on-metal 28-mm cup (Zimmer). Exclusion criteria were posttraumatic osteoarthritis, inflammatory hip disease, secondary hip osteoarthritis, large-diameter metal-on-metal bearings, and non metal-on-metal bearings.
In all, 282 patients were included, 149 with AVN and 133 with osteoarthritis ( Fig. 1 ). Mean age was 47.8 ± 10.2 years (range, 18.5-65.0 years) and mean follow-up was 11.4 ± 2.8 years (range, 4.5-18.3 years). Table 1 lists the causes of AVN and Table 2 the main patient characteristics in the two groups. The AVN group had a younger mean age (44.7 vs. 51.9 years) and higher proportions of males (male/female ratio, 3.68 vs. 1.16) and of patients with bilateral involvement (68 vs. 22). Of the 149 patients with AVN, 51 (34%) had a history of core decompression using an 8-mm trephine followed by autologous cancellous bone grafting.
Surgical procedure
A cementless Omnicase TM stem and cementless 28-mm Schuster cup with a metal-on-metal bearing couple were used in all patients (Fig. 2) . A posterior approach was used in 212/282 patients, with the minimally invasive variant from 2000 onwards [15] . The minimally invasive Rottinger antero-lateral approach was used in 70 patients, 33 with AVN and 37 with osteoarthritis. The approaches were similarly distributed in the two groups (P = 0.20). 
Assessments
Follow-up data including functional and radiographic outcomes were collected on standardized paper forms until 2007 and in an electronic database thereafter (OrthoWaveTM, Aria Software, Arras, France). All data available until 1st September 2014 were recorded for the study. Patients who had not been seen for 2 years or more were contacted. Data of patients who were lost to followup (AVN, n = 12; and osteoarthritis, n = 15) or had died (AVN, n = 14; and osteoarthritis, n = 4) but who had been re-evaluated at least 5 years after THA were included in the analysis. For all patients, data on survival to aseptic loosening, survival to major revision, history of core decompression, and complications were available. The cause of AVN was recorded; when no cause was identified, AVN was classified as idiopathic. The functional outcome at last followup was assessed based on the Postel-Merle d'Aubigné (PMA) score [16] . To evaluate implant osseointegration, the Engh-Massin criteria [17] [18] [19] and Agora Roentgenographic Assessment (ARA) score [20] were determined on the most recent radiographs. Ectopic ossifications were assessed based on the score developed by Brooker et al. [21] .
Statistical methods
According to a posteriori sample size estimation, with the ␣ risk set at 5% and assuming a 6% basal risk of failure to detect a survival difference with 80% power, 246 patients were required in all.
Descriptive statistics were computed after applying the Kolmogorov-Smirnov method to determine whether the data were normally distributed. Between-group comparisons of qualitative variables relied on the Chi-square test, or on Fisher's exact test if the expected theoretical sample size was less than 5. Non-normally distributed quantitative variables were compared using the Mann-Whitney U test or the Wilcoxon test for paired data. Kaplan-Meier survival estimates were computed for two events, aseptic loosening and major revision, with their 95% confidence intervals (95% CIs). The results were compared between groups using the log-rank test.
A Cox regression model was built to identify risk factors for THA failure in patients with AVN. Hazard ratios (HRs) with their 95% CIs were computed to determine whether the cause of AVN or a history of core decompression was associated with THA survival.
Values of P lower than 0.05 were considered significant. Statistical tests were run using SPSS Statistics v21.0 software (Chicago, IL, USA).
Results
Overall, 10-year survival to aseptic loosening was 98.9% (95% CI, 98.2-99.6) and 10-year survival to major revision was 93.9% (95% CI, 98.6-95.5). For neither event was 10-year survival significantly different between the AVN and osteoarthritis groups, given the available sample sizes: aseptic loosening, 98.6% (95% CI, 97.6-98.6) and 99.2% (95% CI, 98.4-100), respectively; and major revision, 92.5% (95% CI, 90.2-94.8) and 95.3% (95% CI, 92.9-97.7), respectively (Table 3) . No patient experienced aseptic loosening or required major revision only at the stem.
Revision for any reason was performed in a larger number of patients with AVN than with osteoarthritis (19 vs. 6; P = 0.018). One or more dislocation episodes occurred in 9 patients with AVN and 3 with osteoarthritis. Revision for dislocation was significantly more common in the AVN group (8 vs. 1; P = 0.031). The number of infections was non-significantly higher in the AVN group (6 vs. 2) ( Table 4 ). Time to revision surgery was significantly shorter in AVN Osseointegration was similar in the AVN and osteoarthritis groups, with the available sample sizes: mean global Engh score, 26.5 ± 1.8 and 26.8 ± 0.9, respectively; mean femoral ARA score, 5.8 ± 0.4 and 5.9 ± 0.4, respectively; and mean acetabular ARA score, 5.7 ± 0.6 and 5.7 ± 0.6 for OA (NS) ( Table 5 ). According to the Engh score, 282 femoral stems were integrated into the bone at last follow-up (global score > 10). According to the ARA score, osseointegration was excellent for 274 (97.2%) femoral stems and 267 (94.7%) cups ( Table 6 ). Ectopic ossifications occurred in similar numbers of patients in the two groups (AVN, n = 7; and osteoarthritis, n = 10) ( Table 7) . A Brooker class IV peri-articular ossification developed in a patient with AVN and required revision surgery due to range-of-motion limitation. Table 7 Ectopic ossifications classified according to Brooker et al. [21] . P-value   Brooker class  NS  I  3  1  II  3  3  III  -6  IV 1 -NS: non-significant.
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Discussion
This study demonstrated good survival of anatomical cementless metal-on-metal 28-mm THA [22] [23] [24] [25] [26] . Overall, 10-year survival was 98.9% (95% CI, 98.2-99.6) for aseptic loosening and 93.9% (95% CI, 98.6-95.5) for major revision. The 10-year survival rates for both events were similar in the AVN and osteoarthritis groups. No patient had aseptic loosening or major revision for the femoral stem only. Survival in the AVN group was consistent with the most recently published data [8, 10, [27] [28] [29] .
This study has several limitations. (a) The sample size was limited, but patients were recruited at a single center, and a single type of implant with a metal-on-metal bearing couple was used. (b) Age and gender distribution differed between the two groups. However, such differences are inevitable, since AVN predominates in young males. (c) The design was not randomized. A case-control comparison with prospective data collection was performed instead. Furthermore, the post hoc sample size estimation for the primary outcome supports the validity of our findings. (d) We did not assess patient satisfaction or quality of life (e.g., using the SF-36 or WOMAC). Nevertheless, the PMA score is a good and robust indicator of functional outcome. (e) Measurements on radiographs are subject to bias. However, Orthowave software enables a systematic analysis of the images and provides reproducible measurements. (f) Metal ion assays were not performed routinely but Table 5 Implant osseointegration assessed using the Engh score [17] and Agora Roentgenographic Assessment (ARA) score [20] in the groups with avascular necrosis and osteoarthritis (means values with their 95% confidence intervals).
Overall population
Avascular necrosis Osteoarthritis P-value Global Engh [17] 26.66 ± 1.46 (14-27) 26.51 ± 1.81 (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) 26.84 ± 0.91 (19.5-27) 0.065 Engh Fixation [17] 9.78 ± 1.05 (3-10) 9.68 ± 1.25 (3-10) 9.88 ± 0.74 (5-10) 0.115 Engh Stability [17] 16.88 ± 0.73 (9) (10) (11) (12) (13) (14) (15) (16) (17) 18.82 ± 0.97 (9) (10) (11) (12) (13) (14) (15) (16) (17) 16.96 ± 0.31 (14.5-17) 0.198 ARA Femur [20] 5.86 ± 0.44 (3-6) 5.83 ± 0.46 (3-6) 5.90 ± 0.42 (3-6) 0.064 ARA Cup [20] 5.76 ± 0.66 (3-6) 5.74 ± 0.67 (3-6) 5.78 ± 0.66 (3-6) 0.344 Table 6 Comparison of implant osseointegration assessed in categories based on the Engh score [17] and Agora Roentgenographic Assessment (ARA) score [20] in the groups with avascular necrosis and osteoarthritis. are not recommended for monitoring small-diameter metal-onmetal implants [30] . (g) Activity levels were not measured, but our primary objective was to compare survival to aseptic loosening and major revision after metal-on-metal 28-mm THA for AVN vs. osteoarthritis. To achieve this objective, the sample size was adequate, as shown by the sample size estimation, and the follow-up seems sufficient.
Revision for any reason was more common in the AVN group (19 vs. 6 ; P = 0018). One or more episodes of dislocation requiring reduction occurred in 9 patients with AVN and 3 with osteoarthritis, and revisions for dislocation were significantly more common in the AVN group (8 vs. 1; P = 0.031). Time to revision was significantly shorter in the AVN group (4.07 ± 3.95 years [range, 0.08-10.23] vs. 7.98 ± 2.31 years [range, 4.4-10.9], P = 0.035).
Our results are consistent with those of recent studies showing that THA survival in AVN has improved markedly, up to the values seen in THA for osteoarthritis. Before 1993, a survival rate of 38% was reported after 10 years. Since then, survival has increased to above 80% while remaining lower compared to osteoarthritis [3] [4] [5] [6] [7] [8] . A recent study by Bedard et al. [27] of 80 cementless metal-onpolyethylene THAs in AVN showed that 10-year survival was 100% for aseptic loosening and 93% for major revision. Issa et al. [31] studied 78 cases of cementless THA for AVN and found survival rates to aseptic loosening of 98% after 5 years and 96.5% after 10 years. Another study, by Kim et al. [29] , included 74 patients with femoral head AVN who underwent metal-on-polyethylene or ceramic-onpolyethylene THA. Survival to femoral aseptic loosening was 96.6% after 10 and 16 years.
The cup was the main reason for major revision, in accordance with earlier data [10, 27] . Good osseointegration of the stem allows preservation of this component during major revision [32, 33] . The anatomical cementless Omnicase TM stem has excellent longevity, with a 100% survival rate for both aseptic loosening and major revision in our study. This stem is rectilinear in the coronal plane and curved in the sagittal plane. It fills the femoral canal in both planes, a characteristic associated with stability and osseointegration [34] .
Few studies have compared THA outcomes between AVN and osteoarthritis [3, 4, 7, 35] . In 1989, Saito et al. [4] reported a comparison of 29 AVN and 63 osteoarthritis cases managed with cemented THA. After a mean follow-up of 7 years, functional outcomes were poorer in the AVN group, which had a 28% major revision rate compared to 6% in the osteoarthritis group (P < 0.005) [4] , leading the authors to conclude that patients with AVN were at high risk for THA failure. Another comparison of AVN and osteoarthritis was reported in 1999 by Ortiguera et al. [7] , who included 94 patients in each group. A cemented 22-mm Charnley prosthesis was used in both groups. After the mean follow-up of 17.8 years, survival to major revision was not significantly different between the two groups. However, aseptic loosening, particularly of the stem, was more common in the AVN group, which also had a higher frequency of revision for dislocation (7 vs. 1; P < 0.05). Revision was far more common in the subgroup of patients with osteoarthritis who were younger than 50 years, in which the major revision rate was 50%, with aseptic loosening being the reason for revision in 79% of cases [7] . In 2008, Steinberg et al. [35] reported a significantly higher major revision rate in AVN than in osteoarthritis, due chiefly to a large number of major revisions of the femoral component.
Conclusion
For many years, THA outcomes were poorer in AVN than in other hip diseases. Our results, in contrast, show similar outcomes in AVN and in osteoarthritis. An anatomical cementless femoral stem with a 28-mm cup and metal-on-metal bearings provides lasting good outcomes in fairly young patients with high activity levels.
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